These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9714416)

  • 21. Light chain-associated amyloid deposits comprised of a novel kappa constant domain.
    Solomon A; Weiss DT; Murphy CL; Hrncic R; Wall JS; Schell M
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9547-51. PubMed ID: 9689117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic and chemical differentiation of human lambda III light chain variable regions.
    Eulitz M; Murphy C; Weiss DT; Solomon A
    J Immunol; 1991 May; 146(9):3091-6. PubMed ID: 1901892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
    Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
    Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro.
    Klafki HW; Pick AI; Pardowitz I; Cole T; Awni LA; Barnikol HU; Mayer F; Kratzin HD; Hilschmann N
    Biol Chem Hoppe Seyler; 1993 Dec; 374(12):1117-22. PubMed ID: 8129857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.
    Blancas-Mejía LM; Martin EB; Williams A; Wall JS; Ramirez-Alvarado M
    Biophys Chem; 2017 Nov; 230():89-98. PubMed ID: 28916410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.
    Hoshii Y; Nanbara H; Cui D; Takahashi M; Ikeda E
    Med Mol Morphol; 2012 Jun; 45(3):124-8. PubMed ID: 23001294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
    Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
    Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biclonal systemic AL-amyloidosis with one glycosylated and one nonglycosylated AL-protein.
    Karimi M; Sletten K; Westermark P
    Scand J Immunol; 2003 Apr; 57(4):319-23. PubMed ID: 12662294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL).
    Fykse EM; Sletten K; Husby G; Cornwell GG
    Biochem J; 1988 Dec; 256(3):973-80. PubMed ID: 3146981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular structure of the amyloid-forming protein kappa I Bre.
    Steinrauf LK; Chiang MY; Shiuan D
    J Biochem; 1999 Feb; 125(2):422-9. PubMed ID: 9990143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
    Lim A; Wally J; Walsh MT; Skinner M; Costello CE
    Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The V kappa III subgroup light chain proteins in AL amyloidosis & autoimmune diseases.
    Alim MA; Hara Y; Kaji H; Shinoda T
    Indian J Med Res; 2001 Jul; 114():30-5. PubMed ID: 11762204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermodynamic modulation of light chain amyloid fibril formation.
    Kim Y; Wall JS; Meyer J; Murphy C; Randolph TW; Manning MC; Solomon A; Carpenter JF
    J Biol Chem; 2000 Jan; 275(3):1570-4. PubMed ID: 10636846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural relationship of lambda-type light chains with AL amyloidosis.
    Alim MA; Yamaki S; Hossain MS; Takeda K; Yamagata F; Takashi I; Shinoda T
    Clin Immunol; 1999 Mar; 90(3):399-403. PubMed ID: 10075869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.
    Wall JS; Kennel SJ; Williams A; Richey T; Stuckey A; Huang Y; Macy S; Donnell R; Barbour R; Seubert P; Schenk D
    PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
    Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
    Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
    Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
    Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
    Solomon A; McLaughlin CL; Capra JD
    J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.